Symrise AG (OTCMKTS:SYIEY – Get Rating) – Jefferies Financial Group reduced their FY2023 EPS estimates for Symrise in a research note issued on Sunday, January 22nd. Jefferies Financial Group analyst C. Counihan now forecasts that the company will post earnings per share of $0.94 for the year, down from their prior estimate of $0.99. The consensus estimate for Symrise’s current full-year earnings is $0.89 per share. Jefferies Financial Group also issued estimates for Symrise’s FY2024 earnings at $1.13 EPS.
Several other equities research analysts also recently weighed in on SYIEY. JPMorgan Chase & Co. increased their price target on Symrise from €107.00 ($116.30) to €110.00 ($119.57) in a report on Monday, December 5th. Berenberg Bank raised shares of Symrise from a “hold” rating to a “buy” rating in a research note on Thursday, January 19th. Finally, The Goldman Sachs Group downgraded shares of Symrise from a “buy” rating to a “neutral” rating in a research note on Sunday, November 27th.
Symrise Price Performance
Symrise AG is a global supplier of fragrances, flavorings, cosmetic active ingredients and raw materials, as well as functional ingredients. It operates through the following three segments: Scent & Care, Flavor and Nutrition. The Scent and Care segment develops, produces and sells fragrances, cosmetic ingredients, aroma molecules and mint aromas.
- Get a free copy of the StockNews.com research report on Symrise (SYIEY)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.